One pill, three battles: drug trial aims to ease depression and chemo sickness for brain cancer patients
NCT ID NCT03935685
Summary
This study is testing if the medication mirtazapine can help newly diagnosed brain cancer patients who are feeling depressed and suffering from severe nausea and vomiting caused by their chemotherapy. Researchers will give the drug to about 36 depressed patients for eight weeks to see if it improves their mood, reduces nausea, and helps them maintain their weight. The main goal is to see if this one medication can safely tackle several difficult side effects at once.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA OF BRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California, 92868, United States
Conditions
Explore the condition pages connected to this study.